Davide Campari-Milano (CPR) Stock Overview
Trades in alcoholic and non-alcoholic beverages in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
CPR Community Fair Values
Create NarrativeSee what 58 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Davide Campari-Milano N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.50 |
| 52 Week High | €6.83 |
| 52 Week Low | €5.27 |
| Beta | 0.45 |
| 1 Month Change | -0.47% |
| 3 Month Change | -11.78% |
| 1 Year Change | -9.36% |
| 3 Year Change | -56.61% |
| 5 Year Change | -51.26% |
| Change since IPO | 645.49% |
Recent News & Updates
Narrative Update • Jun 18
CPR: Margin Support And Earnings Quality Will Drive Constructive Re Rating
Analysts have trimmed their fair value estimate for Davide Campari-Milano to €9.02 from €9.21, reflecting a series of slightly lower Street price targets and modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Street research on Davide Campari-Milano has recently been mixed, with some firms trimming price targets and others making modest upward revisions.
Narrative Update • Jun 04
CPR: Mixed Q1 Delivery And Tariff Headwinds Will Test Higher P E Assumptions
Analysts have trimmed their average price target on Davide Campari-Milano by €0.25. This reflects updated views on the stock after recent target cuts from Citi and RBC that partly offset earlier increases from both firms.Narrative Update • May 21
CPR: Higher P E Assumptions Will Heighten Sensitivity To Mixed Earnings Delivery
Analysts have trimmed their average price target for Davide Campari-Milano by €0.25, reflecting adjustments to revenue growth, profit margin and future P/E assumptions discussed in recent research. Analyst Commentary Recent research on Davide Campari-Milano has been mixed, with some firms nudging targets higher and others trimming expectations.Recent updates
Narrative Update • Jun 18
CPR: Margin Support And Earnings Quality Will Drive Constructive Re Rating
Analysts have trimmed their fair value estimate for Davide Campari-Milano to €9.02 from €9.21, reflecting a series of slightly lower Street price targets and modest tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Street research on Davide Campari-Milano has recently been mixed, with some firms trimming price targets and others making modest upward revisions.Narrative Update • Jun 04
CPR: Mixed Q1 Delivery And Tariff Headwinds Will Test Higher P E Assumptions
Analysts have trimmed their average price target on Davide Campari-Milano by €0.25. This reflects updated views on the stock after recent target cuts from Citi and RBC that partly offset earlier increases from both firms.Narrative Update • May 21
CPR: Higher P E Assumptions Will Heighten Sensitivity To Mixed Earnings Delivery
Analysts have trimmed their average price target for Davide Campari-Milano by €0.25, reflecting adjustments to revenue growth, profit margin and future P/E assumptions discussed in recent research. Analyst Commentary Recent research on Davide Campari-Milano has been mixed, with some firms nudging targets higher and others trimming expectations.Narrative Update • May 06
CPR: Higher P E Assumptions Will Expose Risk Of Overstretched Share Price
Davide Campari-Milano's analyst price targets have edged higher, with recent moves to €6.40, €6.60 and €7.75 as analysts point to updated assumptions on growth, margins and future P/E expectations. Analyst Commentary Recent price target moves and rating changes show a mix of optimism and caution around Davide Campari-Milano, with analysts revisiting assumptions on growth, margins and what investors may be willing to pay on a P/E basis.Narrative Update • Apr 22
CPR: Higher Dividend Visibility And Improved Margin Outlook Will Support Constructive Re Rating
Davide Campari-Milano's analyst price target has been lifted slightly, with recent increases of around €0.25 to €0.60 from several firms, as analysts point to adjustments in fair value, profit margin expectations, and future P/E assumptions. Analyst Commentary Recent research reads as broadly constructive, with several bullish analysts lifting fair value estimates and shifting their stance toward a more balanced view on risk and reward.Narrative Update • Apr 08
CPR: Higher Street Conviction And Dividend Visibility Will Support Constructive Re Rating
Analysts have nudged their average price target for Davide Campari-Milano higher, with recent moves such as Citi lifting its target to €7.75 and RBC Capital to €6.40, while also refining expectations for revenue growth, profit margins and future P/E assumptions. Analyst Commentary Recent Street research points to a more constructive tone around Davide Campari-Milano, with several bullish analysts adjusting their views and targets higher.
Narrative Update • Mar 24
CPR: Higher Future P/E Assumptions Will Support Upside Repricing
The blended analyst price target for Davide Campari-Milano edges higher by about €0.01, supported by recent target increases to €7.75 at Citi, €6.40 at RBC Capital and €6.60 at Oddo BHF, alongside updated analyst assumptions on discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent research updates on Davide Campari-Milano cluster around higher price targets and a moderation in previously cautious views, giving you a clearer picture of how the Street is framing the risk and reward trade off.Narrative Update • Mar 10
CPR: Lower Discount Rate And Higher Future P/E Will Support Upside Potential
Analysts have nudged their average price target for Davide Campari-Milano higher to €7.05, reflecting recent upward revisions in Street targets around €6.40 to €7.75 and updated assumptions on discount rates, margins and future P/E multiples. Analyst Commentary Recent research updates on Davide Campari-Milano point to a tighter range of views around valuation, with several firms revising their price targets and one shifting its rating stance.Narrative Update • Feb 23
CPR: Neutral Rating Shift Will Highlight Risk Of Overstretched Share Price
Analysts have nudged their fair value estimate for Davide Campari-Milano higher to €5.30, reflecting an updated mix of Street views that now includes an upgrade to Neutral with a €6.60 target from Oddo BHF, alongside a recent €0.25 price target trim from Citi. Analyst Commentary Recent Street views on Davide Campari-Milano point to a mixed but cautious tone.Narrative Update • Feb 09
CPR: Refined Discount Rate And Margins Will Support Constructive Re Rating Ahead
Analysts have trimmed their price target on Davide Campari-Milano by €0.25, reflecting updated views on its discount rate, revenue growth assumptions, profit margin outlook, and future P/E expectations. Analyst Commentary Even with the €0.25 trim to the price target, recent research commentary still highlights several supportive points that bullish analysts keep coming back to when they look at Davide Campari-Milano.Analysis Article • Feb 01
With Davide Campari-Milano N.V. (BIT:CPR) It Looks Like You'll Get What You Pay For
Davide Campari-Milano N.V.'s ( BIT:CPR ) price-to-earnings (or "P/E") ratio of 40.5x might make it look like a strong...Narrative Update • Jan 24
CPR: Q3 Margin Outperformance Will Support More Constructive Re Rating Ahead
Analysts have trimmed their fair value estimate for Davide Campari-Milano to €9.43 from €9.64, citing higher revenue growth assumptions, a lower profit margin outlook and a slightly richer future P/E, in line with recent upward price target revisions from Citi, Deutsche Bank and JPMorgan. Analyst Commentary Recent research updates on Davide Campari-Milano point to a more constructive tone, with several bullish analysts revising their fair value views higher and one major bank lifting its rating.Narrative Update • Jan 09
CPR: Q3 EBIT Beat And Margin Strength Will Support Higher Earnings
Analysts have lifted their price targets on Davide Campari-Milano, with recent moves such as Citi's increase to €7.75 from €7.50 and Deutsche Bank's to €6.20 from €5.90, supported by views that include a Q3 EBIT beat of 15% on strong gross margin performance. Analyst Commentary Recent research on Davide Campari-Milano reflects a mix of optimism and caution, with price targets spanning from €6 to €7.75 and ratings ranging from Hold to Buy.Narrative Update • Dec 26
CPR Q3 Margin Strength Will Support Higher Profitability Expectations Ahead
The analyst price target for Davide Campari-Milano has edged higher by approximately EUR 0.25, as analysts cite a strong Q3 EBIT beat, resilient gross margins, and improving profitability expectations despite only modest adjustments to growth and discount rate assumptions. Analyst Commentary Bullish analysts have highlighted the recent Q3 EBIT beat and strong gross margin performance as key drivers behind a series of upward price target revisions for Davide Campari-Milano, reinforcing confidence in the company’s execution and earnings trajectory.Analysis Article • Dec 25
Is Davide Campari-Milano N.V. (BIT:CPR) Trading At A 22% Discount?
Key Insights The projected fair value for Davide Campari-Milano is €7.03 based on 2 Stage Free Cash Flow to Equity...Narrative Update • Dec 11
CPR: Margin Momentum Will Drive Stronger Earnings Expectations Into 2025
Analysts have nudged their average price target on Davide Campari-Milano slightly higher to about EUR 6.88 from EUR 6.76, reflecting stronger margin expectations and a series of recent target hikes and rating upgrades, despite somewhat softer revenue growth assumptions. Analyst Commentary Recent research updates show a gradual improvement in sentiment around Davide Campari-Milano, with several price target increases and rating upgrades balanced by more cautious views on valuation and growth visibility.Analysis Article • Nov 01
Analyst Estimates: Here's What Brokers Think Of Davide Campari-Milano N.V. (BIT:CPR) After Its Third-Quarter Report
Investors in Davide Campari-Milano N.V. ( BIT:CPR ) had a good week, as its shares rose 4.1% to close at €6.03...Analysis Article • Oct 15
We Think Davide Campari-Milano (BIT:CPR) Is Taking Some Risk With Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analysis Article • Sep 08
Calculating The Intrinsic Value Of Davide Campari-Milano N.V. (BIT:CPR)
Key Insights The projected fair value for Davide Campari-Milano is €5.40 based on 2 Stage Free Cash Flow to Equity...Analysis Article • Aug 03
Analyst Estimates: Here's What Brokers Think Of Davide Campari-Milano N.V. (BIT:CPR) After Its Interim Report
Last week saw the newest half-year earnings release from Davide Campari-Milano N.V. ( BIT:CPR ), an important milestone...Analysis Article • Jul 10
Davide Campari-Milano N.V.'s (BIT:CPR) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 36.4x Davide Campari-Milano N.V. ( BIT:CPR ) may be sending very bearish...
New Narrative • Nov 30
Campari's Calculated Brand Focus And Cost Efficiency Drive Future Growth And Profitability
Reorganizing into four brand houses is expected to enhance growth and premiumization, positively impacting revenue.Shareholder Returns
| CPR | IT Beverage | IT Market | |
|---|---|---|---|
| 7D | 0.4% | 0.8% | 3.3% |
| 1Y | -9.4% | 6.0% | 26.8% |
Return vs Industry: CPR underperformed the Italian Beverage industry which returned 6% over the past year.
Return vs Market: CPR underperformed the Italian Market which returned 26.8% over the past year.
Price Volatility
| CPR volatility | |
|---|---|
| CPR Average Weekly Movement | 5.3% |
| Beverage Industry Average Movement | 3.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in IT Market | 8.2% |
| 10% least volatile stocks in IT Market | 2.9% |
Stable Share Price: CPR has not had significant price volatility in the past 3 months compared to the Italian market.
Volatility Over Time: CPR's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1860 | 4,807 | Simon Hunt | www.camparigroup.com |
Davide Campari-Milano N.V., together with its subsidiaries, trades in alcoholic and non-alcoholic beverages in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers a range of products, including aperitifs, vodka, whisky, rum, agave, cognac, and champagne under the Aperol, Campari, Picon, Cynar, Sarti Rosa, Campari Soda, Crodino, Aperol Spritz RTE, Wild Turkey, Appleton Estate, Wray and Nephew, The GlenGrant, Wilderness Trail, Espolòn, Ancho Reyes, Montelobos, Grand Marnier, Courvoisier, Bisquit, Champagne Lallier, SKYY Vodka, Bulldog Gin, Averna, Braulio, Forty Creek, Frangelico, Cabo Wabo, Del Professore, Mondoro, Riccadonna, La Mauny, Trois Rivieres, Kingston 62, O’ndina, Bickens, Dreher, Ouzo 12, Sagabita, and Zedda Piras brand names. Davide Campari-Milano N.V. was founded in 1860 and is headquartered in Sesto San Giovanni, Italy.
Davide Campari-Milano N.V. Fundamentals Summary
| CPR fundamental statistics | |
|---|---|
| Market cap | €6.59b |
| Earnings (TTM) | €346.30m |
| Revenue (TTM) | €3.05b |
19.0x
P/E Ratio2.2x
P/S RatioIs CPR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CPR income statement (TTM) | |
|---|---|
| Revenue | €3.05b |
| Cost of Revenue | €1.21b |
| Gross Profit | €1.84b |
| Other Expenses | €1.49b |
| Earnings | €346.30m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Jul 29, 2026
| Earnings per share (EPS) | 0.29 |
| Gross Margin | 60.31% |
| Net Profit Margin | 11.35% |
| Debt/Equity Ratio | 68.0% |
How did CPR perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield35%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/06 23:36 |
| End of Day Share Price | 2026/07/06 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Davide Campari-Milano N.V. is covered by 36 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Paola Saglietti | Banca Akros S.p.A. (ESN) |
| Laurence Whyatt | Barclays |
| Mandeep Sangha | Barclays |